Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Share News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM, EGM Calendar - Week Ahead

Wed, 29th Apr 2015 05:14

UK AGM, EGM Calendar
Wednesday, April 29
Segro
MTI Wireless Edge
Countrywide
British American Tobacco
Aggreko
Aviva
HellermannTyton
Kennedy Wilson Europe Real Estate
EMIS
Global Invacom Group
Nichols
Admiral
Aberdeen UK Tracker Trust 
Asian Total Return Investment Company 
Devro
Fidessa Group
Lancashire Holdings
Alliance Trust
Weir Group
Polar Capital Global Financials Trust 
EP Global Opportunities Trust
London Stock Exchange Group
Thursday, April 30
Berendsen
Alkane Energy
Colt Group
Ashtead Group
James Fisher & Sons
Synthomer
Ultra Electronics Holdings
Modern Water
Schroders
Tullow Oil
Anglo Pacific
STV Group
Witan Investment Trust
LSL Property
IndigoVision
ARM Holdings
GLI Finance
International Personal Finance
Moneysupermerket.com
RIT Capital Partners
Unilever
Everyman Media Group
Fyffes
BT
H&T Group
Friday, May 1
Aer Lingus
SVG Capital
Jardine Lloyd Thompson Group
Virgin Money
Fairpoint
Electric Word
Capital & Counties Properties
RPS Group
Smurfit Kappa
Silence Therapeutics
Monday, May 4
No Events Scheduled 
Tuesday, May 5
Catlin Group
Randgold Resources
Macfarlane Group
BG Group
Burford Capital
GVC Holdings
Henderson High Income
Spirent Communications
Stratex International
Sherborne Investors
 
Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
21 Aug 2020 10:21

Silence Therapeutics Files Registration Statement For ADS Listing

Silence Therapeutics Files Registration Statement For ADS Listing

Read more
16 Jul 2020 14:28

Silence Therapeutics To Develop Two More RNA Assets For Mallinckrodt

Silence Therapeutics To Develop Two More RNA Assets For Mallinckrodt

Read more
23 Jun 2020 10:14

Silence Therapeutics makes 'exceptional' year-to-date progress

(Sharecast News) - RNA therapeutics developer Silence Therapeutics said on Tuesday that it had continued to make "exceptional progress" in securing additional high-value partnerships and advancing its proprietary pipeline year-to-date.

Read more
29 May 2020 17:18

UK DIRECTOR DEALINGS SUMMARY: Moya Greene Buys GBP50,000 In easyJet

UK DIRECTOR DEALINGS SUMMARY: Moya Greene Buys GBP50,000 In easyJet

Read more
12 May 2020 15:45

Director dealings: Silence Therapeutics CFO lowers stake

(Sharecast News) - Silence Therapeutics revealed on Tuesday that chief financial officer Rob Quinn had offloaded of 89,054 ordinary shares in the AIM-listed biotechnology group.

Read more
12 May 2020 15:35

UK DIRECTOR DEALINGS SUMMARY: Silence CFO Sells GBP360,000 Worth

UK DIRECTOR DEALINGS SUMMARY: Silence CFO Sells GBP360,000 Worth

Read more
14 Apr 2020 15:21

Silence Therapeutics 2019 Loss Widens On Higher Research Costs

Silence Therapeutics 2019 Loss Widens On Higher Research Costs

Read more
9 Apr 2020 14:54

UK TRADING UPDATE SUMMARY: Naked Wines, Distil Get Bar-Closure Boost

UK TRADING UPDATE SUMMARY: Naked Wines, Distil Get Bar-Closure Boost

Read more
7 Apr 2020 16:11

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
2 Apr 2020 13:07

UK EXECUTIVE CHANGE SUMMARY: Iofina Recruits Former Oklahoma Governor

UK EXECUTIVE CHANGE SUMMARY: Iofina Recruits Former Oklahoma Governor

Read more
25 Mar 2020 10:52

UK WINNERS & LOSERS SUMMARY: Rentokil Falls After Scrapping Dividend

UK WINNERS & LOSERS SUMMARY: Rentokil Falls After Scrapping Dividend

Read more
25 Mar 2020 09:48

Silence Therapeutics Agrees Strategic Collaboration With AstraZeneca

Silence Therapeutics Agrees Strategic Collaboration With AstraZeneca

Read more
27 Jan 2020 09:36

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts Ashtead And Raises DCC

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts Ashtead And Raises DCC

Read more
7 Jan 2020 15:43

Silence Therapteutics inks deal with Takeda after decent year

(Sharecast News) - Serious disease therapeutics developer Silence Therapeutics updated the market on the year ended 31 December on Tuesday, reporting that it has entered into a technology evaluation agreement with Takeda to explore the potential of using its platform to generate siRNA molecules against a novel, undisclosed target discovered by Takeda.

Read more
7 Jan 2020 10:40

Silence Therapeutics Plans New US Subsidiary; Inks Deal With Takeda

Silence Therapeutics Plans New US Subsidiary; Inks Deal With Takeda

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.